Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRC24
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,589
Award facts
- Contract value 100% obligated
- $11,589.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on June 16, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 ml formulation at a ceiling value of $11,589.13. The contract is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen Drug Corp's headquarters location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects the company's ongoing role as a primary source for pharmaceutical supply chain support, enabling the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities to access necessary medications and medical supplies through a flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DB25FRC24?
SPE2DB25FRC24 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FRC24 worth?
The government has obligated $11,589 on SPE2DB25FRC24.
Is contract SPE2DB25FRC24 an order under another contract?
Yes. SPE2DB25FRC24 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRC24 competed?
The extent of competition for SPE2DB25FRC24 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award